Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Mar 06, 2023

SELL
$5.96 - $8.53 $643 - $921
-108 Reduced 23.13%
359 $2,000
Q3 2022

Nov 02, 2022

SELL
$5.95 - $14.3 $2,136 - $5,133
-359 Reduced 43.46%
467 $1,000
Q2 2022

Aug 12, 2022

SELL
$10.6 - $13.28 $42,548 - $53,305
-4,014 Reduced 82.93%
826 $9,000
Q1 2022

May 13, 2022

SELL
$10.37 - $12.73 $9,063 - $11,126
-874 Reduced 15.3%
4,840 $55,000
Q4 2021

Feb 14, 2022

BUY
$10.21 - $15.27 $2,123 - $3,176
208 Added 3.78%
5,714 $63,000
Q3 2021

Nov 12, 2021

SELL
$14.07 - $17.3 $984 - $1,211
-70 Reduced 1.26%
5,506 $79,000
Q2 2021

Aug 10, 2021

BUY
$16.62 - $18.94 $1,495 - $1,704
90 Added 1.64%
5,576 $95,000
Q1 2021

May 11, 2021

BUY
$15.15 - $19.78 $44,434 - $58,014
2,933 Added 114.88%
5,486 $94,000
Q4 2020

Feb 12, 2021

BUY
$16.86 - $19.67 $41,543 - $48,466
2,464 Added 2768.54%
2,553 $46,000
Q3 2020

Nov 13, 2020

SELL
$15.4 - $20.16 $246 - $322
-16 Reduced 15.24%
89 $1,000
Q2 2020

Aug 12, 2020

SELL
$18.24 - $21.45 $2,389 - $2,809
-131 Reduced 55.51%
105 $2,000
Q1 2020

May 12, 2020

BUY
$16.28 - $25.63 $3,842 - $6,048
236 New
236 $5,000
Q4 2019

Feb 07, 2020

SELL
$19.57 - $23.52 $5,068 - $6,091
-259 Closed
0 $0
Q3 2019

Nov 12, 2019

SELL
$19.85 - $22.76 $7,741 - $8,876
-390 Reduced 60.09%
259 $5,000
Q2 2019

Aug 09, 2019

BUY
$17.59 - $21.1 $8,372 - $10,043
476 Added 275.14%
649 $14,000
Q1 2019

May 10, 2019

BUY
$18.01 - $20.11 $3,115 - $3,479
173 New
173 $3,000
Q2 2018

Jul 31, 2018

SELL
$20.16 - $24.68 $9,737 - $11,920
-483 Closed
0 $0
Q1 2018

May 09, 2018

BUY
$20.31 - $24.95 $9,809 - $12,050
483 New
483 $10,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.31B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Rockefeller Capital Management L.P. Portfolio

Follow Rockefeller Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.